Methods for stereoselective polyene cyclization

By using an acidic sulfonamide Brønsted acid catalyst, the reaction of compounds with formula (II) solves the problems of low efficiency and poor selectivity in the production of ambroxol and succinyl lactone in the prior art, and realizes the synthesis of tricyclic compounds with high yield and high selectivity.

CN122122137APending Publication Date: 2026-05-29BASF SE +1

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
BASF SE
Filing Date
2024-10-31
Publication Date
2026-05-29

AI Technical Summary

Technical Problem

Existing technologies are difficult to efficiently and enantioselectively produce ambroxol and succinyl lactone from readily available precursors such as citral and nerolidol. Furthermore, existing methods require highly corrosive acids, low temperatures, and toxic solvents, or rely on expensive enzymatic catalysts.

Method used

A catalytic amount of acidic sulfonamide-based Brønsted acid catalyst is used to react a compound having formula (II) under specific conditions to form a tricyclic compound having formula (I), including the use of an acidic sulfonamide moiety having 1 to 20 carbon atoms as a catalyst.

Benefits of technology

It achieves high yield and good diastereoselectivity, forming diastereomers mainly linked by trans, with yields typically >30%, trans:cis ratio >80:20, and forming all-trans diastereomers to epi-diastereomers in a ratio >1:1, avoiding unwanted cis isomers.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122122137A_ABST
    Figure CN122122137A_ABST
Patent Text Reader

Abstract

The present invention relates to a process for stereoselective polyene cyclization to produce tricyclic compounds of formula (I), wherein X is CH2or C=O, comprising reacting a compound of formula (II), wherein X is CH2or C=O and wherein the curved line indicates the E- or Z-configuration, in the presence of a catalytic amount of a Bronsted acid having an acidic sulfonamide moiety.(I)(II)
Need to check novelty before this filing date? Find Prior Art